A three-year study of tirzepatide – a medication approved ... such as high blood pressure or heart disease. Like similar drugs, it’s used as a shot patients give themselves once a week and ...

Zepbound and Mounjaro reduce the risk of developing type 2 diabetes by 94% in people who have prediabetes and obesity or overweight.

The drug company says Tirzepatide cuts the risk of progression to diabetes by 94% in adults with pre-diabetes and obesity.

heart and stroke in adult patients with CV disease who have obesity or are overweight. Still, the pressure is on for Novo ...

New study results found weight loss and diabetes drugs Zepbound and Mounjaro may significantly cut the risk of ... study that found its drug tirzepatide slashed the risk of developing type 2 ...

New research finds that people who catch up on z’s on their days off can cut their risk of heart disease by up to 20%. “Sufficient compensatory sleep is linked to a lower risk of heart disease ...